Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

TheFly published on November 26, 2025, that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

As the year draws to a close, we take a look at some of the biggest science stories of the year, and why they matter.

In one of the rockiest years yet for science, Philadelphia-area researchers still managed to celebrate many wins. Here are five of them.

For all of the political chaos that American science endured in 2025, aspects of this country’s research enterprise made it ...

Researchers call the development a "game-changer" for aquaculture, signalling how precision genetics may increasingly ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $53.19, marking a -1.45% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.14%. At ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Biju Dharmapalan [email protected] India’s journey toward becoming a self-sufficient and self-reliant nation has been ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Syngas biomethanation—converting CO/CO₂/H₂ into renewable methane—relies on coordinated microbial interactions. This study reveals that excess ...